WRENTHAM — The majority owner of New England Compounding Center and her husband were sentenced to probation and fined Wednesday in U.S. District Court in Boston in connection with illegally withdrawing cash following a 2012 fungal meningitis outbreak traced to the lab.
Carla Conigliaro, 53, of Dedham, the majority owner of NECC, was sentenced by U.S. District Court Judge Richard Stearns to one year of probation and ordered to pay a fine of $4,500, according to the U.S. Attorney’s Office.
Her husband, Douglas Conigliaro, 55, also of Dedham, was sentenced to two years of probation and ordered to pay a fine of $55,000.
They pleaded guilty in July to withdrawing cash from their bank accounts in a manner intended to defeat financial reporting requirements.
The charges were the results of the couple’s actions following a 2012 nationwide outbreak of fungal meningitis traced to contaminated vials of preservative-free methylprednisolone acetate manufactured by NECC, a compounding pharmacy in Framingham.
The couple began withdrawing unusual sums of cash from their personal bank account starting in October 2012, the day a search warrant was executed at NECC. The cash transactions were structured by the Conigliaros in a manner so as to evade the $10,000 reporting requirement for the filing of a currency transaction report.
The Conigliaros admitted to withdrawing $124,000 in cash in this manner, prosecutors said.
In December 2014, following a two-year investigation, the Conigliaros and 12 other employees and associates, including NECC’s owner and head pharmacist Barry J. Cadden of Wrentham, were charged in a federal indictment.
The indictment did not charge the Conigliaros with having an active role in the operations or management of NECC, but did charge them with transferring assets following the fungal meningitis outbreak.
Cadden, of 13 Manchester Drive in Wrentham, and supervisory pharmacist Glenn A. Chin were charged with 25 racketeering acts of second-degree murder in seven states. They are scheduled to stand trial Jan. 5.
Ten other defendants, including six pharmacists, the director of operations, the national sales director, an unlicensed pharmacy technician, and another owner, were charged with additional crimes including racketeering, mail fraud, conspiracy and violations of the Food, Drug and Cosmetic Act.